减重步态训练改善老年骨关节炎患者下肢关节功能的临床研究

注册号:

Registration number:

ChiCTR2000037303 

最近更新日期:

Date of Last Refreshed on:

2020-10-12 07:14:58 

注册时间:

Date of Registration:

2020-08-27 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

减重步态训练改善老年骨关节炎患者下肢关节功能的临床研究

Public title:

The clinical study of weight-loss gait training on improving lower limb joint function in elderly patients with osteoarthritis

注册题目简写:

English Acronym:

研究课题的正式科学名称:

减重步态训练改善老年骨关节炎患者下肢关节功能的临床研究

Scientific title:

The clinical study of weight-loss gait training on improving lower limb joint function in elderly patients with osteoarthritis

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

梁晓昱 

研究负责人:

梁晓昱 

Applicant:

Liang Xiaoyu 

Study leader:

Liang Xiaoyu 

申请注册联系人电话:

Applicant telephone:

+86 13681910038

研究负责人电话:

Study leader's
telephone:

+86 13681910038

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

ryoxy@foxmail.com

研究负责人电子邮件:

Study leader's E-mail:

ryoxy@foxmail.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市黄浦区普安路185号曙光医院住院部7楼医生办公室

研究负责人通讯地址:

上海市黄浦区普安路185号曙光医院住院部7楼医生办公室

Applicant address:

7th Floor, Inpatient Department, Shuguang Hospital, 185 Pu'an Road, Huangpu District, Shanghai

Study leader's address:

7th Floor, Inpatient Department, Shuguang Hospital, 185 Pu'an Road, Huangpu District, Shanghai

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海中医药大学附属曙光医院

Applicant's institution:

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

研究负责人所在单位:

上海中医药大学附属曙光医院

Affiliation of the Leader:

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2020-sgys-019

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海中医药大学附属曙光医院伦理委员会

Name of the ethic committee:

Ethics Committee of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2020-08-24 00:00:00

伦理委员会联系人:

马俊坚

Contact Name of the ethic committee:

Ma Junjian

伦理委员会联系地址:

上海市浦东新区张衡路528号

Contact Address of the ethic committee:

528 Zhangheng Road, Pudong New Area, Shanghai

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海中医药大学附属曙光医院

Primary sponsor:

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

上海市黄浦区普安路185号曙光医院住院部7楼医生办公室

Primary sponsor's address:

7th Floor, Inpatient Department, Shuguang Hospital, 185 Pu'an Road, Huangpu District, Shanghai

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海中医药大学附属曙光医院

具体地址:

浦东新区张衡路528号

Institution
hospital:

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Address:

528 Zhangheng Road, Pudong New Area

经费或物资来源:

上海申康医院发展中心

Source(s) of funding:

Shanghai Shenkang Hospital Development Center

研究疾病:

骨关节炎  

Target disease:

Osteoarthritis

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

用减重步态训练系统,结合体外冲击波治疗,治疗老年骨关节炎(膝关节炎、髋关节炎)患者,通过FMA评分、ADL评分,10m步行能力;骨钙素、β-CTX、骨密度、膝髋部X线、膝/髋关节活动度、力量、僵硬度及安全性指标等,确定临床疗效,改善下肢关节功能,减轻患者疼痛,提高患者运动耐力,改善生活质量。  

Objectives of Study:

Use weight loss gait training system, combined with extracorporeal shock wave therapy, to treat elderly patients with osteoarthritis (knee arthritis, hip arthritis) through FMA score, ADL score, 10m walking ability; osteocalcin, β-CTX, bone mineral density , Knee and hip X-rays, knee/hip joint range of motion, strength, stiffness and safety indicators, etc., to determine clinical efficacy, improve lower limb joint function, reduce patient pain, improve patient exercise endurance, and improve quality of life.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

①严重骨质疏松症患者;
②有新发急性骨折未愈者;
③伴有严重的原发疾病者或精神病患者。

Exclusion criteria:

1. Patients with severe osteoporosis;
2. Patients with new acute fractures unhealed;
3. Patients with severe primary disease or mental illness.

研究实施时间:

Study execute time:

From 2020-09-01 00:00:00 To 2022-08-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-09-01 00:00:00 To 2022-08-31 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

80

Group:

experimental group

Sample size:

干预措施:

减重步态训练系统

干预措施代码:

Intervention:

Use weight loss gait training system

Intervention code:

组别:

对照组

样本量:

80

Group:

control group

Sample size:

干预措施:

体外冲击波治疗

干预措施代码:

Intervention:

RESW

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

CHINA

Province:

Shanghai

City:

单位(医院):

上海中医药大学附属曙光医院 

单位级别:

三级甲等 

Institution
hospital:

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

下肢运动功能

指标类型:

主要指标

Outcome:

FMA-L

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

10 m步行能力测试

指标类型:

主要指标

Outcome:

10 m walking ability test

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

日常生活能力评分

指标类型:

次要指标

Outcome:

ADL评分量表

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

膝/髋关节活动度

指标类型:

次要指标

Outcome:

Knee/hip joint range of motion

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

骨钙素

指标类型:

次要指标

Outcome:

Osteocalcin

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

β-CTX

指标类型:

次要指标

Outcome:

β-CTX

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

膝髋部X线

指标类型:

次要指标

Outcome:

X-ray

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

左心功能测定

指标类型:

次要指标

Outcome:

LVEF

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血常规

指标类型:

副作用指标

Outcome:

Blood routine

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

骨密度

指标类型:

次要指标

Outcome:

Bone density

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心电图

指标类型:

副作用指标

Outcome:

EKG

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血沉

指标类型:

副作用指标

Outcome:

ESR

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

凝血

指标类型:

副作用指标

Outcome:

Blood clotting

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肝功能

指标类型:

副作用指标

Outcome:

liver function

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肾功能

指标类型:

副作用指标

Outcome:

Kidney function

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

聘请专业统计人员借助SAS统计分析系统PROCPLAN过程给定种子数,受试者按照随机方法分配至试验组和对照组,

Randomization Procedure (please state who generates the random number sequence and by what method):

Hire professional statisticians to use the SAS statistical analysis system PROCPLAN process to specify the number of seeds. Subjects are assigned to the test group and the control group according to a random method.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

开放

Blinding:

open-label

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

ResMan临床试验公共管理平台;http://www.medresman.org.cn.

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Clinical Trial Management Public Platform; http://www.medresman.org.cn.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

临床病例采集表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-08-27 23:52:16